A neuroscience medical group built on multimodal assessment, a physician-review closed loop and L1-L4 tiered data de-identification — covering internet hospital, clinic network, specialty centers, cognitive rehabilitation and AI research.

Online consultation, e-prescription, pharmacist review, multi-store pharmacy and nursing follow-up.

Standardized chain clinics under one group platform for consistent care close to patients.

PD, AD, CI and Stroke centers plus an ASD program with longitudinal follow-up.

Digital cognitive assessment and rehabilitation training with patient education.

Scale, speech and behavior multimodal assessment, always reviewed by physicians.

Internal research demo covering subject client, preset assets, fusion results and physician review desk, validating the full multimodal and de-identification pipeline.

RBAC staff management, patient management, drug GSP lots, order settlement, marketing & in-store dispensing, quality-control sampling, CMS and reconciliation - one console for the whole group.
Raw voice and behavior data are feature-ized on-device; identifier and assessment stores are physically separated.
AI recommends; licensed physicians decide. Review feedback continuously improves the models.
Data access, de-identification actions and model versions are logged and replayable.
P1/P2/P3 application dossiers finalized, to be filed via Shenzhen IP Protection Center fast track.
R&DPD/AD/CI/Stroke tablet-based collection endpoints deployed for standardized in-hospital CRF acquisition.
GroupPatient H5 officially released, connecting online consultation, e-prescription and nursing follow-up.
GroupClinic partnership · Patent licensing · Device registration · IR